Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors. (2021)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/antib10040044
PubMed Identifier: 34842612
Publication URI: http://europepmc.org/abstract/MED/34842612
Type: Journal Article/Review
Volume: 10
Parent Publication: Antibodies (Basel, Switzerland)
Issue: 4
ISSN: 2073-4468